Erste Asset Management Gmb H Biogen Inc. Transaction History

Erste Asset Management Gmb H

$7.79 Trillion
Q1 2025

A detailed history of Erste Asset Management Gmb H transactions in Biogen Inc. stock. As of the latest transaction made, Erste Asset Management Gmb H holds 50,956 shares of BIIB stock, worth $6.84 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

50,956

Previous 59,316 14.09%

Holding current value

$6.84 Million

Previous $8.98 Billion 21.44%

% of portfolio

0.09%

Previous 0.11%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$133.43 - $153.27 $1.12 Million - $1.28 Million	-8,360 Reduced 14.09%	50,956 $7.05 Billion
Q4 2024 Feb 10, 2025	SELL	$146.47 - $191.55 $33.4 Million - $43.7 Million	-228,307 Reduced 79.38%	59,316 $8.98 Billion
Q3 2024 Nov 14, 2024	BUY	$189.07 - $236.8 $54.4 Million - $68.1 Million	287,623 New	287,623 $55.8 Billion
Q2 2024 Nov 26, 2024	BUY	$190.52 - $236.72 $3.79 Million - $4.71 Million	19,903 Added 7.53%	284,317 $65.6 Billion
Q1 2024 Nov 26, 2024	SELL	$212.02 - $267.71 $2.23 Million - $2.81 Million	-10,498 Reduced 3.82%	264,414 $57.1 Billion
Q4 2023 Nov 26, 2024	BUY	$222.59 - $267.94 $62,992 - $75,827	283 Added 0.1%	274,912 $71.3 Billion
Q3 2023 Nov 26, 2024	BUY	$253.3 - $285.89 $9.67 Million - $10.9 Million	38,182 Added 16.15%	274,629 $70.6 Billion
Q2 2023 Nov 26, 2024	BUY	$275.25 - $318.06 $704,915 - $814,551	2,561 Added 0.95%	273,096 $77.6 Billion
Q1 2023 Nov 26, 2024	BUY	$256.56 - $292.34 $14 Million - $15.9 Million	54,475 Added 25.21%	270,535 $75 Billion
Q4 2022 Nov 26, 2024	BUY	$252.44 - $306.72 $941,853 - $1.14 Million	3,731 Added 1.6%	236,447 $65.4 Billion
Q3 2022 Nov 26, 2024	SELL	$194.69 - $268.46 $13.9 Million - $19.2 Million	-71,563 Reduced 24.88%	216,060 $57.6 Billion
Q2 2022 Nov 26, 2024	BUY	$187.54 - $223.02 $34.6 Million - $41.2 Million	184,629 Added 383.95%	232,716 $47.5 Billion
Q1 2022 Nov 22, 2024	BUY	$193.77 - $244.14 $2.22 Million - $2.8 Million	11,467 Added 4.91%	245,117 $51.7 Billion
Q4 2021 Nov 22, 2024	SELL	$223.92 - $287.77 $8.72 Million - $11.2 Million	-38,958 Reduced 13.54%	248,665 $61 Billion
Q3 2021 Nov 22, 2024	BUY	$282.99 - $369.05 $3.2 Million - $4.18 Million	11,315 Added 5.09%	233,650 $66.3 Billion
Q2 2021 Nov 22, 2024	BUY	$259.0 - $414.71 $6.63 Million - $10.6 Million	25,598 Added 13.01%	222,335 $77 Billion
Q1 2021 Nov 22, 2024	SELL	$242.95 - $284.63 $44,945 - $52,656	-185 Reduced 0.09%	196,737 $54.8 Billion
Q4 2020 Nov 22, 2024	BUY	$236.26 - $355.63 $34.2 Million - $51.5 Million	144,825 Added 277.99%	196,922 $48 Billion
Q3 2020 Nov 22, 2024	SELL	$264.77 - $305.71 $62.4 Million - $72 Million	-235,526 Reduced 81.89%	52,097 $14.7 Billion
Q2 2020 Nov 22, 2024	SELL	$258.66 - $342.55 $5.26 Million - $6.97 Million	-20,333 Reduced 21.85%	72,734 $19 Billion
Q1 2020 Nov 22, 2024	SELL	$268.85 - $341.04 $24.2 Million - $30.7 Million	-90,140 Reduced 49.2%	93,067 $29.3 Billion
Q4 2019 Nov 22, 2024	SELL	$220.06 - $304.07 $23 Million - $31.7 Million	-104,416 Reduced 36.3%	183,207 $54.6 Billion
Q3 2019 Nov 22, 2024	BUY	$217.44 - $243.88 $103,066 - $115,599	474 Added 1.2%	40,092 $9.24 Billion
Q2 2019 Nov 22, 2024	SELL	$219.29 - $241.72 $8.75 Million - $9.65 Million	-39,914 Reduced 50.19%	39,618 $9.45 Billion
Q1 2019 Nov 22, 2024	SELL	$216.71 - $338.96 $45.1 Million - $70.5 Million	-208,091 Reduced 72.35%	79,532 $18.5 Billion
Q4 2018 Nov 26, 2024	SELL	$278.5 - $352.75 $66.7 Million - $84.5 Million	-239,536 Reduced 83.28%	48,087 $14.2 Billion

Others Institutions Holding BIIB

# of Institutions

1,026

Shares Held

127M

Call Options Held

2.29M

Put Options Held

4.26M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $19.3B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Erste Asset Management Gmb H with notifications on news.

Account

Erste Asset Management Gmb H Biogen Inc. Transaction History